- New Jersey ASC performs robotic spine surgery milestone
- Aviation, hospitality and the NFL: What dentistry can learn from other industries
- HCA California system names COO
- Virginia expands noncompete limits for terminated employees
- Over half of dental professionals dealing with burnout: Report
- Parkview Health breaks ground on freestanding ED, urgent care facility
- 64% of Americans worry about healthcare costs: 6 notes
- MD Anderson appoints inaugural chief nurse executive
- Children’s Mercy plans $1B+ patient care tower
- AI detects pancreatic cancer 3 years before diagnosis: Mayo Clinic
- Hospital finance leaders zero in on capacity optimization + workforce effectiveness as margins remain thin
- Jefferson Health lands $1.7M grant for hypertension care
- CMS may have improperly paid $2.26M for virtual services: Audit
- GLP-1 semaglutide tied to vision risk: Study
- NYC Health + Hospitals launches avian flu preparedness program
- 22 behavioral health executive moves to know
- The ‘significant opportunity’ Talkspace will bring to UHS
- Physician lawsuit rates hit historic lows, but malpractice premiums are soaring: AMA
- The potential ‘litigation wave’ headed for GI
- ASCs’ multi-billion dollar savings potential
- Dental’s new cash-pay anesthesia opportunity
- The new cash-pay anesthesia opportunity
- UHS-owned behavioral health facility to lay off 648 employees
- PeaceHealth physician group switch-up heads to court
- Why ophthalmology ASCs have a built-in advantage
- Georgia Southern University to begin construction of new dental school
- Oregon institute receives $3M cardiovascular gift
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Tennessee dental school to open clinic in Kentucky
- Federal autism committee outlines policy, care gaps in HHS letter
- Tennessee provider expands virtual behavioral health urgent care
- Chicago invests $16.2M in mental health, street psychiatry program
- US suicide rate declines 2%: 5 things to know
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- Lawmakers introduce bill to expand mental health clinics
- What 5 dentists would do differently in their careers
- Psychedelics show promise but are ‘not a solution’ to mental healthcare gap, MGB leader says
- Beyond the note: How ambient AI solves behavioral health’s unique challenges
- CareQuest, NxtCare partner to integrate oral health with home-based care
- Heartland Dental adds Texas practice
- 6 dental deals totaling $148M
- Viewpoint: Dentistry needs to ‘outsmart’ the insurance industry
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Haleon scores branding goal with star-studded soccer offensive
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Utah Medical Licensing Board urges state to shut down Doctronic AI prescribing pilot
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- Solace Health expands care navigation services to commercially insured patients
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs
- Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts
- Haleon nabs Google exec Richard Manso as US chief marketing officer
- Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026
- Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
- AMA urges lawmakers to implement stronger safeguards for AI chatbots in mental health
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- Ligand snaps up fellow biotech royalty aggregator Xoma for $739M
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- The Help That Many Older Americans Need Most
- UnityAI builds out agentic AI for staffing operations to match outpatient clinicians with patient demand
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- In Connecticut, Doctors and Dentists Are More Likely Than Hospitals To Sue Patients
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- Lawmakers introduce bipartisan legislation to improve access, quality of care in Medicare Advantage plans
- HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- ‘What the Health?’ Podcast: RFK Jr. vs. Congress
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Health Tech Weekly Rundown: Google invests in AI training for rural health workers; State of genAI adoption in healthcare
- UnitedHealthcare, Aetna, Cigna tout progress to standardize prior authorization as part of industry-wide commitment
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- A look at payers' attitudes toward specialty drug management
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Keynote Remarks at The Economic Club of Washington
- Rethinking Prior Authorization for Better Outcomes
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- A look at the National Academy of Medicine’s Change Maker Accelerators Program
The US District Court, southern Florida district, has issued a temporary restraining order to halt operations of this multi-pronged insurance sales operating nationwide.
The case is entitled FTC v.
NNOVATIVE PARTNERS, LP, d/b/a
INNOVATIVE HEALTH PLAN or
HEALTHCARE PLAN; AMERICAN
COLLECTIVE, LP, d/b/a
ACLP HEALTH PLAN; HEALTH PLAN
ADMINISTRATORS, LLC; PAPYRUS
GREEN INVESTMENTS LLC; AHMED
IBRAHIM SHOKRY; AMERICAN
COLLECTIVE, LP; PAPYRUS
GREEN INVESTMENTS LLC; and
AMANI IBRAHIM SHOKRY; Defendants.
Telemarketers like these are hated for good reason.
FTC Sues to Stop Deceptive Health Care Scheme
FTC alleges scheme has generated millions of dollars by deceiving consumers seeking comprehensive health plans or those who already have coverage
April 22, 2026
At the Federal Trade Commission’s request, a U.S. district court in Florida has temporarily halted a nationwide operation that allegedly impersonates the government and large insurance carriers to deceive consumers seeking health insurance into buying supposedly comprehensive PPO plans that do not offer the coverage they seek.
According to the Commission’s complaint, the scheme—which operates under several names including Innovative Partners and American Collective—also targets already-insured consumers by claiming they need to pay to maintain or renew coverage. The FTC alleges that consumers paid the defendants millions in “premiums” for products they did not want or need, and which expose them to potentially significant and unexpected medical costs.
This action follows FTC Chairman Andrew N. Ferguson’s creation of a Healthcare Task Force in March, as well as the FTC’s prior enforcement efforts against related healthcare schemes.
“Targeting unlawful conduct that drives up Americans’ costs, especially healthcare costs, is one of my top priorities,” said Chairman Andrew N. Ferguson. “The Healthcare Task Force launched last month underscores my commitment to bringing the full strength of the agency to bear on the challenges facing American patients, providers, and communities. The Commission’s work here is essential: When companies engage in practices that inflate prices, limit patient access to medical care, or undermine the integrity of the healthcare system, consumers suffer. Under my leadership, the Commission will continue to pursue fraudsters who deceive or disadvantage people seeking medical treatment, and we will do so with every enforcement tool at my disposal.”
The FTC alleges that since at least early 2023, the six defendants named in the complaint have jointly operated a fraudulent telemarketing scheme that takes advantage of consumers seeking comprehensive health insurance coverage. In making their pitch, the defendants often falsely tell consumers they are buying “state issued” PPO insurance policies that have no deductible and provide full coverage with low or no co-payments, according to the complaint.
The complaint further alleges that when dealing with consumers who already have health insurance, the company’s telemarketers deceptively tell them they are calling from real insurance carriers or the government, and that without immediate payment their policies will be canceled.
The products the defendants sell are not PPO plans or comprehensive health insurance policies, and they cannot be sold on any state or federal government health insurance marketplace, according to the complaint. Instead, the defendants’ plans typically include an assortment of medical discounts, ancillary products, and capped payouts for certain medical events such as emergency room visits—while some plans exclude hospital care entirely.
While at least one defendant has claimed they do not market or sell insurance, the defendants lead consumers to believe the products they offer—which can cost hundreds of dollars a month and thousands of dollars a year—will provide comprehensive coverage, according to the complaint.
The complaint further alleges that when consumers who enroll in the defendants’ supposed PPO policies attempt to use them, they discover that the products do not provide the comprehensive coverage they were promised. As a result, some are forced to postpone care until they can get insurance coverage, while others are faced with substantial medical debt. When frustrated consumers try to cancel their purchase of the products, the defendants often ignore them and the monthly payments continue.
In addition, the complaint alleges that the defendants:
- unfairly charge consumers without their express, informed consent and fail to disclose material terms and conditions of their negative option feature, specifically the steps consumers must take to cancel the monthly recurring payments;
- make misrepresentations while telemarketing and fail to disclose material information in telemarketing before the consumer consents to pay for the goods or services provided;
- engage in unlawful telemarketing acts and practices by charging consumers for products or services for which they have not provided their express, informed consent;
- deceptively pose as businesses and government officials or misrepresent their affiliation with, or endorsement or sponsorship by, a government entity; and
- use false, fictitious, or fraudulent statements or representations to obtain customer information of a financial institution, such as credit or debit card numbers.
The complaint alleges that the defendants violated the FTC Act, the Telemarketing Sales Rule, the Impersonation Rule, and the Gramm-Leach-Bliley Act and seeks refunds for affected consumers. The court entered a temporary restraining order against the defendants based on their alleged law violations.
The Commission vote authorizing the staff to file the complaint against the six defendants was 2-0. The complaint was filed under seal in the U.S. District Court for the Southern District of Florida, and the seal has now been lifted.
The defendants include Innovative Partners, LP, which does business as Innovative Health Plan or Healthcare Plan, and its Chief Technology Officer Amani Ibrahim Shokry; American Collective, LP, which does business as ACLP Health Plan; Papyrus Green Investments LLC; and their owner Ahmed Ibrihim Shokry, as well as Health Plan Administrators, LLC.
NOTE: The Commission files a complaint when it has “reason to believe” that the named defendants are violating or are about to violate the law and it appears to the Commission that a proceeding is in the public interest. The case will be decided by the court.
Staff attorneys on this matter are Matthew Schiltz, William Hodor, and D’Laney Gielow of the FTC’s Midwest Region.
The Federal Trade Commission works to promote competition and protect and educate consumers. The FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov. Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













